UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

Journal of molecular neuroscience, 2004-01, Vol.23 (1-2), p.115-122

2004

Volltextzugriff (PDF)

Quantification of amyloid-beta 40 in cerebrospinal fluid

Journal of immunological methods, 2009-08, Vol.348 (1), p.57-66

2009

Volltextzugriff (PDF)

Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies

Clinical chemistry and laboratory medicine, 2006, Vol.44 (2), p.192-195

2006

Volltextzugriff (PDF)

β-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Annals of neurology, 2003-08, Vol.54 (2), p.263-267

2003

Volltextzugriff (PDF)

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

Dementia and geriatric cognitive disorders, 2008-03, Vol.25 (3), p.256-265

2008

Volltextzugriff (PDF)

Electrophoretic separation of amyloid β peptides in plasma

Electrophoresis, 2004-10, Vol.25 (20), p.3336-3343

2004

Volltextzugriff (PDF)

Selective reduction of amyloid 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid peptide aggregation

Journal of neurology, neurosurgery and psychiatry, 2006-10, Vol.77 (10), p.1201-1203

Mollenhauer, B

2006

Volltextzugriff (PDF)

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

Proteomics. Clinical applications, 2008-10, Vol.2 (10-11), p.1548-1556

2008

Volltextzugriff (PDF)

Amyloid beta peptides in plasma in early diagnosis of Alzheimer' s disease: A multicenter study with multiplexing

Experimental neurology, 2010-06, Vol.223 (2), p.366-370

2010

Volltextzugriff (PDF)

Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Dementia and geriatric cognitive disorders, 2007-01, Vol.23 (1), p.22-28

2007

Volltextzugriff (PDF)

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing : Beta-amylid and tau protein abnormalities in Alzheimer's disease

Experimental neurology, 2010, Vol.223 (2), p.366-370

2010

Volltextzugriff (PDF)

Validation of amyloid- peptides in CSF diagnosis of neurodegenerative dementias

Molecular psychiatry, 2007-07, Vol.12 (7), p.671-680

2007

Volltextzugriff (PDF)

Reduced CSF carboxyterminally truncated Abeta peptides in frontotemporal lobe degenerations

Journal of neural transmission (Vienna, Austria : 1996), 2007, Vol.114 (5), p.621-628

2007

Volltextzugriff (PDF)

Beta-amyloid-Peptid-Spektrum im Liquor von Patienten mit Chorea Huntington

Aktuelle Neurologie, 2005, Vol.32 (S 4)

2005

Volltextzugriff (PDF)

Tau-protein und Beta-amyloid (1–42) im Liquor bei Lewy-Body- und Parkinson-Demenz

Aktuelle Neurologie, 2005, Vol.32 (S 1)

2005

Volltextzugriff (PDF)

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Dementia and geriatric cognitive disorders, 2005-05, Vol.19 (5-6), p.376-382

2005

Volltextzugriff (PDF)

CSF Tau, phospho-Tau181 and amyloid-β 38/40/42 in frontotemporal dementia and pimary progressive aphasia

Aktuelle Neurologie, 2009, Vol.36 (S 02)

2009

Volltextzugriff (PDF)

The concentrations of amyloid beta 1–42, total Tau and phospho-Tau181 in the CSF of patients with early dementia and MCI as measured with multiplexing technology

Pharmacopsychiatry, 2005, Vol.38 (5)

2005

Volltextzugriff (PDF)

Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation

Journal of neurology, neurosurgery and psychiatry, 2006-10, Vol.77 (10), p.1201-1203

2006

Volltextzugriff (PDF)

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Journal of neurochemistry, 2002-05, Vol.81 (3), p.481-496

2002

Volltextzugriff (PDF)

Tauopathies and synucleinopathies: Do cerebrospinal fluid [beta]-amyloid peptides reflect disease-specific pathogenesis?

Journal of neural transmission, 2007-07, Vol.114 (7), p.919

2007

Volltextzugriff (PDF)

Reduced CSF carboxyterminally truncated A[beta] peptides in frontotemporal lobe degenerations

Journal of neural transmission, 2007-05, Vol.114 (5), p.621

2007

Volltextzugriff (PDF)

Einfluss von multimodaler sportlicher Aktivität auf Kognition und Alltagskompetenzen bei früher Alzheimer-Demenz (SPORT&KOG)

Zeitschrift für Gerontopsychologie & -psychiatrie, 2008-09, Vol.21 (3), p.163-169

2008

Volltextzugriff (PDF)

Biomarkers of bone metabolism in horses: Ante-mortem versus post-mortem correlation in serum and aqueous humour

Veterinary and comparative orthopaedics and traumatology, 2002-01, Vol.15 (2), p.67-71

2002

Volltextzugriff (PDF)

The VLF Transmitter, Narrowband Receiver, and Tuner Investigation on the DSX Spacecraft

Journal of geophysical research. Space physics, 2023-07, Vol.128 (7), p.n/a

2023

Volltextzugriff (PDF)

26 – 50 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(39)
Humans
(32)
Aged
(25)
Male
(25)
Female
(24)
Middle Aged
(22)
Neurosciences & Neurology
(22)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(19)
Cerebrospinal Fluid
(19)
Alzheimer's Disease
(17)
Neurology
(17)
Aged, 80 And Over
(16)
Alzheimer Disease - Cerebrospinal Fluid
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Neurosciences
(15)
Alzheimer Disease - Diagnosis
(14)
Clinical Neurology
(14)
Biomarkers - Cerebrospinal Fluid
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

Quantification of amyloid-beta 40 in cerebrospinal fluid

Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies

β-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

Electrophoretic separation of amyloid β peptides in plasma

Selective reduction of amyloid 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid peptide aggregation

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

Amyloid beta peptides in plasma in early diagnosis of Alzheimer' s disease: A multicenter study with multiplexing

Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing : Beta-amylid and tau protein abnormalities in Alzheimer's disease

Validation of amyloid- peptides in CSF diagnosis of neurodegenerative dementias

Reduced CSF carboxyterminally truncated Abeta peptides in frontotemporal lobe degenerations

Beta-amyloid-Peptid-Spektrum im Liquor von Patienten mit Chorea Huntington

Tau-protein und Beta-amyloid (1–42) im Liquor bei Lewy-Body- und Parkinson-Demenz

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

CSF Tau, phospho-Tau181 and amyloid-β 38/40/42 in frontotemporal dementia and pimary progressive aphasia

The concentrations of amyloid beta 1–42, total Tau and phospho-Tau181 in the CSF of patients with early dementia and MCI as measured with multiplexing technology

Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Tauopathies and synucleinopathies: Do cerebrospinal fluid [beta]-amyloid peptides reflect disease-specific pathogenesis?

Reduced CSF carboxyterminally truncated A[beta] peptides in frontotemporal lobe degenerations

Einfluss von multimodaler sportlicher Aktivität auf Kognition und Alltagskompetenzen bei früher Alzheimer-Demenz (SPORT&KOG)

Biomarkers of bone metabolism in horses: Ante-mortem versus post-mortem correlation in serum and aqueous humour

The VLF Transmitter, Narrowband Receiver, and Tuner Investigation on the DSX Spacecraft

Suchergebnisse filtern